GLP-1 weight loss drugs: insights and solutions
IGD’s knowledge resources on GLP‑1s help businesses navigate the implications of weight loss medicines. As these medications gain momentum, questions are emerging around their impact on consumer decision making, shopping behaviours and engagement with food. Early signals show growing relevance for food, drink and eating out.
New GLP-1 programme
IGD’s GLP‑1 subscription programme combines primary research, behavioural insight and data led analysis to identify what matters now and what to watch next.
Bookmark this page to stay up to date with the evolving GLP‑1 landscape.
Interested in our programme?
Contact us to get started and stay ahead of the GLP-1 shift.
See more insight on GLP-1
50 total results
Loading content...
Loading content...